“With this new release, the Android has joined our existing supported devices, making PEPID available on every major smartphone, including iPhone, BlackBerry, Windows Mobile and Palm Pre,” says John Wagner, president. “We continue to welcome user feedback on our latest platform.”

PEPID recently conducted a beta program for the application, and had an overwhelming response as the application was widely praised and accepted by testers.

PEPID is recognized as having the most extensive drug database on the market today, along with thousands of disease profiles and medical conditions, medical and dosing calculators, a drug interactions checker, illustrations, laboratory values and a differential diagnosis generator — all of which are now available for the Android.

“The new PEPID Android application takes advantage of the device’s intuitive user interface and capabilities,” says Edward Reynolds, chief technology officer. “The fast, easy-to-search GUI of the Android has allowed us to add features such as a sliding ‘quicklinks’ menu to help users navigate our clinical and drug content faster, as well as a notes capability unique to the Android.”

The PEPID application is available for purchase or download at pepid.com/android, and a complimentary toxicology reference in available from Android Market.

PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care.

PEPID has provided clinical specialty-focused products since 1994, focusing on the way healthcare professionals practice medicine.

PEPID offers one of the most robust medical information resources on the market as well as some of the best customer service in the industry.

Learn more at pepid.com/android.